Drugs / Dengzhanxixin Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05700097 | Sep 2022 → Sep 2023 | ischemic stroke | Beijing Tiantan Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dengzhanxixin Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05700097 ↗ |
| Route | Intravenous | “slowly intravenously infused once a day” NCT05700097 ↗ |